KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to $9.5 million.

  • Acadia Pharmaceuticals' Other Non-Current Assets rose 7.99% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 7.99%. This contributed to the annual value of $8.8 million for FY2024, which is 51.99% up from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Other Non-Current Assets of $9.5 million as of Q3 2025, which was down 0.00% from $9.5 million recorded in Q2 2025.
  • Acadia Pharmaceuticals' 5-year Other Non-Current Assets high stood at $9.5 million for Q2 2025, and its period low was $5.8 million during Q1 2021.
  • In the last 3 years, Acadia Pharmaceuticals' Other Non-Current Assets had a median value of $8.1 million in 2023 and averaged $7.5 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Other Non-Current Assets declined by 28.94% in 2024 and then spiked by 64.14% in 2025.
  • Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Other Non-Current Assets stood at $5.8 million in 2021, then remained steady at $5.8 million in 2022, then remained steady at $5.8 million in 2023, then spiked by 51.99% to $8.8 million in 2024, then rose by 7.99% to $9.5 million in 2025.
  • Its Other Non-Current Assets stands at $9.5 million for Q3 2025, versus $9.5 million for Q2 2025 and $8.8 million for Q1 2025.